LMP517

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Difilippantonio, Simone: 1 article (01/2020)
2.	Huang, Shar-Yin N: 1 article (01/2020)
3.	James, Amy: 1 article (01/2020)
4.	Marzi, Laetitia: 1 article (01/2020)
5.	Pommier, Yves: 1 article (01/2020)
6.	Sun, Yilun: 1 article (01/2020)

1.	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/01/2020 - "LMP517 showed better antitumor activity than its parent compound LMP744 against H82 (small cell lung cancer) xenografts. "
2.	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/01/2020 - "Genetic analyses in DT40 cells showed a dual TOP1 and TOP2 signature with selectivity of LMP517 for DNA repair-deficient tyrosyl DNA phosphodiesterase 2 (TDP2)- and Ku70-knockout cells. "

1.	tyrosyl-DNA phosphodiesterase